Theranostic Advances in Breast Cancer in Nuclear Medicine

Area of Science:

• Oncology
• Nuclear Medicine
• Radiopharmaceutical Therapy

Background:

• Theranostics involves using identical receptors for simultaneous or separate diagnostic and therapeutic applications with the same radioligand.
• Significant advancements have been made in developing theranostic tracers in recent years.
• Nuclear medicine is increasingly adopting a diagnostic-based therapeutic strategy.

Purpose of the Study:

• To review targeted radiopharmaceuticals for breast cancer.
• To focus on theranostic applications in breast cancer imaging and therapy.

Main Methods:

• Literature review of theranostic tracers.
• Focus on radiopharmaceuticals targeting breast cancer receptors.

Main Results:

• Numerous theranostic tracers have been developed.
• Evidence supports the integration of diagnosis and therapy in nuclear medicine.
• Specific examples of targeted radiopharmaceuticals for breast cancer are presented.

Conclusions:

• Theranostic approaches are a growing trend in nuclear medicine.
• Targeted radiopharmaceuticals offer promising avenues for breast cancer management.
• The review provides examples of radiopharmaceuticals for breast cancer theranostics.